Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Ecancermedicalscience|January 26, 2012
A randomised trial evaluating bevacizumab as adjuvant therapy following resection of AJCC stage IIB, IIC and III cutaneous melanoma: an updateS Biswas, J Wrigley, C East, et al.
ESMO Open|April 30, 2022
Antibiotic use reduces efficacy of tyrosine kinase inhibitors in patients with advanced melanoma and non-small-cell lung cancerN Tinsley, C Zhou, S Nahm, et al.
British Journal of Cancer|September 2, 1999
Investigation of female survival benefit in metastatic melanomaB Richardson, A Price, M Wagner, et al.
Pigment Cell Research|October 21, 2000
Oestrogenic steroids and melanoma cell interaction with adjacent skin cells influence invasion of melanoma cells in vitroS M Neil, P Eves, B Richardson, et al.
British Journal of Cancer|July 31, 2008
Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancerS Baka, R Califano, R Ferraldeschi, et al.
Endocrine Connections|June 23, 2018
SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapyC E Higham, A Olsson-Brown, P Carroll, et al.
British Journal of Cancer|September 14, 2006
Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancerS C White, P Lorigan, G P Margison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 17, 2005
Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status </= 70) and advanced non-small-cell lung cancerS Baka, L Ashcroft, H Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2014
Prevalence and correlates of unmet supportive care needs in patients with resected invasive cutaneous melanomaA Molassiotis, L Brunton, J Hodgetts, et al.
Lung Cancer (Amsterdam, Netherlands)|June 22, 2006
Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancerS Baka, C Manegold, E Buchholz, et al.
Pageof 7